Literature DB >> 9005853

Identification of a gene that causes primary open angle glaucoma.

E M Stone1, J H Fingert, W L Alward, T D Nguyen, J R Polansky, S L Sunden, D Nishimura, A F Clark, A Nystuen, B E Nichols, D A Mackey, R Ritch, J W Kalenak, E R Craven, V C Sheffield.   

Abstract

Glaucoma is a major cause of blindness and is characterized by progressive degeneration of the optic nerve and is usually associated with elevated intraocular pressure. Analyses of sequence tagged site (STS) content and haplotype sharing between families affected with chromosome 1q-linked open angle glaucoma (GLC1A) were used to prioritize candidate genes for mutation screening. A gene encoding a trabecular meshwork protein (TIGR) mapped to the narrowest disease interval by STS content and radiation hybrid mapping. Thirteen glaucoma patients were found to have one of three mutations in this gene (3.9 percent of the population studied). One of these mutations was also found in a control individual (0.2 percent). Identification of these mutations will aid in early diagnosis, which is essential for optimal application of existing therapies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9005853     DOI: 10.1126/science.275.5300.668

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  456 in total

Review 1.  World blindness: a 21st century perspective.

Authors:  H R Taylor; J E Keeffe
Journal:  Br J Ophthalmol       Date:  2001-03       Impact factor: 4.638

Review 2.  Locally administered ocular corticosteroids: benefits and risks.

Authors:  Charles N J McGhee; Simon Dean; Helen Danesh-Meyer
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

3.  The OPA1 gene and optic neuropathy.

Authors:  W L M Alward
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

4.  Glaucoma: our role in reducing the burden of blindness.

Authors:  Lenworth N Johnson
Journal:  J Natl Med Assoc       Date:  2002-10       Impact factor: 1.798

5.  Interaction of recombinant myocilin with the matricellular protein SPARC: functional implications.

Authors:  José-Daniel Aroca-Aguilar; Francisco Sánchez-Sánchez; Sikha Ghosh; Ana Fernández-Navarro; Miguel Coca-Prados; Julio Escribano
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-05       Impact factor: 4.799

6.  Olfactomedin 4 down-regulates innate immunity against Helicobacter pylori infection.

Authors:  Wenli Liu; Ming Yan; Yueqin Liu; Ruihong Wang; Cuiling Li; Chuxia Deng; Aparna Singh; William G Coleman; Griffin P Rodgers
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

7.  Distributions of p53 codon 72 polymorphism in primary open angle glaucoma.

Authors:  H-J Lin; W-C Chen; F-J Tsai; S-W Tsai
Journal:  Br J Ophthalmol       Date:  2002-07       Impact factor: 4.638

Review 8.  Cellular and molecular biology of optineurin.

Authors:  Hongyu Ying; Beatrice Y J T Yue
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

Review 9.  Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine.

Authors:  M Elizabeth Fini; Stephen G Schwartz; Xiaoyi Gao; Shinwu Jeong; Nitin Patel; Tatsuo Itakura; Marianne O Price; Francis W Price; Rohit Varma; W Daniel Stamer
Journal:  Prog Retin Eye Res       Date:  2016-09-22       Impact factor: 21.198

10.  Epitope mapping of commercial antibodies that detect myocilin.

Authors:  Athéna C Patterson-Orazem; Shannon E Hill; Michael P Fautsch; Raquel L Lieberman
Journal:  Exp Eye Res       Date:  2018-05-09       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.